No connection

Search Results

DHR vs SYK

DHR
Danaher Corporation
NEUTRAL
Price
$195.50
Market Cap
$138.36B
Sector
Healthcare
AI Confidence
85%
SYK
Stryker Corporation
NEUTRAL
Price
$329.69
Market Cap
$126.27B
Sector
Healthcare
AI Confidence
80%

Valuation

P/E Ratio
DHR
38.94
SYK
39.2
Forward P/E
DHR
21.49
SYK
19.69
P/B Ratio
DHR
2.63
SYK
5.62
P/S Ratio
DHR
5.63
SYK
5.03
EV/EBITDA
DHR
19.57
SYK
19.86

Profitability

Gross Margin
DHR
59.23%
SYK
65.04%
Operating Margin
DHR
22.17%
SYK
27.23%
Profit Margin
DHR
14.71%
SYK
12.92%
ROE
DHR
7.05%
SYK
15.08%
ROA
DHR
4.18%
SYK
7.92%

Growth

Revenue Growth
DHR
4.6%
SYK
11.4%
Earnings Growth
DHR
12.5%
SYK
55.9%

Financial Health

Debt/Equity
DHR
0.37
SYK
0.73
Current Ratio
DHR
1.87
SYK
1.89
Quick Ratio
DHR
1.4
SYK
1.04

Dividends

Dividend Yield
DHR
0.82%
SYK
1.07%
Payout Ratio
DHR
25.45%
SYK
40.48%

AI Verdict

DHR NEUTRAL

Danaher Corporation presents a dichotomy between strong operational quality and poor valuation metrics. The deterministic baseline is weak, with a Piotroski F-Score of 4/9 (Stable) and a current price of $195.50 that significantly exceeds both the Graham Number ($91.62) and the Intrinsic Value ($129.26). While the balance sheet is exceptionally healthy with low debt/equity (0.37), the stock is trading at a steep premium. Despite a 'Strong Buy' analyst consensus and a high target price of $256.05, the bearish technical trend and insider selling suggest caution.

Strengths
Very low Debt/Equity ratio (0.37) indicating high financial solvency
Strong Gross Margins (59.23%) reflecting significant pricing power
Consistent long-term track record of earnings beats over 25 quarters
Risks
Significant overvaluation relative to Graham and Intrinsic value models
Bearish technical trend (0/100) and negative 6-month price performance
Slow organic revenue growth (4.60% YoY)
SYK NEUTRAL

SYK shows neutral fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Mixed signals with both opportunities and risks present.

Strengths
Strong financial trend (Piotroski F-Score: 7/9)
Strong ROE of 15.1%
Risks
High valuation with P/E of 39.2
Premium vs Graham Number ($105.31)

Compare Another Pair

DHR vs SYK: Head-to-Head Comparison

This page compares Danaher Corporation (DHR) and Stryker Corporation (SYK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile